Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,905 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Potential role of ADAMTS13 in the progression of alcoholic hepatitis.
Uemura M, Fujimura Y, Matsuyama T, Matsumoto M, Ishikawa M, Ishizashi H, Kato S, Tsujimoto T, Fujimoto M, Yoshiji H, Morioka C, Fukui H. Uemura M, et al. Among authors: ishikawa m. Curr Drug Abuse Rev. 2008 Jun;1(2):188-96. doi: 10.2174/1874473710801020188. Curr Drug Abuse Rev. 2008. PMID: 19630717 Review.
Localization of ADAMTS13 to the stellate cells of human liver.
Uemura M, Tatsumi K, Matsumoto M, Fujimoto M, Matsuyama T, Ishikawa M, Iwamoto TA, Mori T, Wanaka A, Fukui H, Fujimura Y. Uemura M, et al. Among authors: ishikawa m. Blood. 2005 Aug 1;106(3):922-4. doi: 10.1182/blood-2005-01-0152. Epub 2005 Apr 26. Blood. 2005. PMID: 15855280 Free article.
Decreased activity of plasma ADAMTS13 may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis.
Uemura M, Matsuyama T, Ishikawa M, Fujimoto M, Kojima H, Sakurai S, Ishii S, Toyohara M, Yamazaki M, Yoshiji H, Yamao J, Matsumoto M, Ishizashi H, Fujimura Y, Fukui H. Uemura M, et al. Among authors: ishikawa m. Alcohol Clin Exp Res. 2005 Dec;29(12 Suppl):264S-71S. doi: 10.1097/01.alc.0000192326.08931.cb. Alcohol Clin Exp Res. 2005. PMID: 16385234
Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis.
Matsuyama T, Uemura M, Ishikawa M, Matsumoto M, Ishizashi H, Kato S, Morioka C, Fujimoto M, Kojima H, Yoshiji H, Takimura C, Fujimura Y, Fukui H. Matsuyama T, et al. Among authors: ishikawa m. Alcohol Clin Exp Res. 2007 Jan;31(1 Suppl):S27-35. doi: 10.1111/j.1530-0277.2006.00283.x. Alcohol Clin Exp Res. 2007. PMID: 17331163
Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis.
Uemura M, Fujimura Y, Matsumoto M, Ishizashi H, Kato S, Matsuyama T, Isonishi A, Ishikawa M, Yagita M, Morioka C, Yoshiji H, Tsujimoto T, Kurumatani N, Fukui H. Uemura M, et al. Among authors: ishikawa m. Thromb Haemost. 2008 Jun;99(6):1019-29. doi: 10.1160/TH08-01-0006. Thromb Haemost. 2008. PMID: 18521503
Plasma ADAMTS13 activity parallels the APACHE II score, reflecting an early prognostic indicator for patients with severe acute pancreatitis.
Morioka C, Uemura M, Matsuyama T, Matsumoto M, Kato S, Ishikawa M, Ishizashi H, Fujimoto M, Sawai M, Yoshida M, Mitoro A, Yamao J, Tsujimoto T, Yoshiji H, Urizono Y, Hata M, Nishino K, Okuchi K, Fujimura Y, Fukui H. Morioka C, et al. Among authors: ishikawa m. Scand J Gastroenterol. 2008;43(11):1387-96. doi: 10.1080/00365520802179933. Scand J Gastroenterol. 2008. PMID: 18609162
Potential role of enhanced cytokinemia and plasma inhibitor on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis: relationship to endotoxemia.
Ishikawa M, Uemura M, Matsuyama T, Matsumoto M, Ishizashi H, Kato S, Morioka C, Fujimoto M, Kojima H, Yoshiji H, Tsujimoto T, Takimura C, Fujimura Y, Fukui H. Ishikawa M, et al. Alcohol Clin Exp Res. 2010 Feb;34 Suppl 1:S25-33. doi: 10.1111/j.1530-0277.2008.00850.x. Epub 2009 Dec 16. Alcohol Clin Exp Res. 2010. PMID: 19094193
Combined treatment of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates hepatic dysplastic nodule in a patient with liver cirrhosis.
Yoshiji H, Noguchi R, Yamazaki M, Ikenaka Y, Sawai M, Ishikawa M, Kawaratani H, Mashitani T, Kitade M, Kaji K, Uemura M, Yamao J, Fujimoto M, Mitoro A, Toyohara M, Yoshida M, Fukui H. Yoshiji H, et al. Among authors: ishikawa m. World J Gastroenterol. 2007 Jun 21;13(23):3259-61. doi: 10.3748/wjg.v13.i23.3259. World J Gastroenterol. 2007. PMID: 17589909 Free PMC article.
[A case of intrahepatic splenosis].
Ishikawa M, Tsujimoto T, Uemura M, Kawaratani H, Fujimoto M, Hirai T, Kuriyama S, Fukui H. Ishikawa M, et al. Nihon Shokakibyo Gakkai Zasshi. 2007 Dec;104(12):1758-65. Nihon Shokakibyo Gakkai Zasshi. 2007. PMID: 18057854 Japanese.
Development of hepatocellular carcinoma in a patient 13 years after sustained virological response to interferon against chronic hepatitis C: a case report.
Mashitani T, Yoshiji H, Yamazaki M, Ikenaka Y, Noguchi R, Ishikawa M, Kawaratani H, Matsuo N, Uemura M, Yamao J, Fujimoto M, Mitoro A, Toyohara M, Yoshida M, Sawai M, Morioka C, Tsujimoto T, Kitade M, Kaji K, Aihara Y, Fukui H. Mashitani T, et al. Among authors: ishikawa m. Cases J. 2009 Jan 7;2(1):18. doi: 10.1186/1757-1626-2-18. Cases J. 2009. PMID: 19128460 Free PMC article.
3,905 results